This research demonstrates dual regulation of HEPN RNase toxicity in FhepTA systems, suggesting novel regulatory mechanisms.
Enzymatic toxins targeting nucleic acids are a widespread strategy for resolving biological conflicts. Ubiquitous HEPN domain-containing proteins harbor a conserved RNase motif and are found in both prokaryotes and eukaryotes. In prokaryotes, HEPN domain toxins frequently pair with adjacent MNT domain antitoxins to form the prevalent type VII HepT/MntA toxin-antitoxin (TA) system. Here, we identified a group of fused MNT-HEPN proteins (renamed FhepTA) carried by mobile genetic elements in the Shewanella genus; these proteins show high similarity to the HepT/MntA TA systems. When encoded as separate genes, the MntA antitoxin oligoAMPylates the HEPN domain toxin HepT to block its toxicity. While FhepTA toxicity is also blocked by oligoAMPylation, it is additionally regulated by a redox switch involving two unique cysteines within its HEPN domain. Furthermore, the N-terminal MNT domain intrinsically inhibits toxicity by preventing dimerization of the C-terminal HEPN domain. Thus, the fused MNT-HEPN architecture represents a new family of TA modules potentially regulated in both ATP-dependent (via oligoAMPylation) and redox-state-dependent oligomerization.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: